Notifications
Back

 Launching

Business Area
Product / Project
2019
2020
2021
2022
2023
2024
Current Status
Topical
Hemostats
Tableau Wax (Bone hemostat)

 






Available in market
OOZFIX (Powder type)

 

 





Available in market
CuraPad

 

 

 

 



Approved (KFDA)
TAB-503PM (Granule type)

 

 

 

 



In progress for KFDA approval
TAB-505ED (Endoscopic)

 

 

 

 



In progress for KFDA approval
ActiClot (Flowable hemostatic matrix)

 

 

 

 



Approved (KFDA)
TAB-517TP (Active powder type)

 

 

 

 



In progress for KFDA approval
Surgical Sealants & Adhesives
TAB-601PG (Biodegradable polymer)

 

 

 

 

 


Under Developing
TAB-602PS (Polymer patch)

 

 

 

 

 


Under Developing
Soft-Tissue Reinforcement Products
TAB-301PS (Biodegradable membrane)

 

 

 

 

 

 

Prototyping
TAB-302PVS (Non-degradable membrane)

 

 

 

 

 

 

Under Developing
TAB-303PXS (Composite membrane)

 

 

 

 

 


Under Developing

R&D Portfolio

™ is a trademark of Theracion Biomedical Corporation.

® is a registered trademark of Theracion biomedical Corporation.

For Pet Animal
Click Here
For Pet Animal
Click Here

이전섹션백업

Speciality Biomaterials & Hemostasis Technology

Theracion Biomedical
Speciality Biomaterials & Hemostasis Technology




Learn More

Theracion Biomedical
Speciality Biomaterials & Hemostasis Technology




Learn More

Technology toward a better future
Speciality Biomaterials & Hemostasis Technology




Learn More

R&D toward first healthcare option
Speciality Biomaterials & Hemostasis Technology




Learn More

NEW INNOVATIVE SPECIALTY

BIOMATEIALS & HEMOSTASIS TECHNOLOGY

Theracion Biomedical Corp., outstanding research group in the field of biomaterial based medical device, has concentrated its in-house technology of biocompatible / biodegradable polymeric biomaterial.

Such biomaterial platform technology of Theracion Biomedical Corp. is integrated with drug delivery system(DDS) and/or biological dimension to develop cutting-edge medical devices converged with pharmaceuticals and tissue engineering.

Theracion Biomedical is certified to ISO 9001:2008.



Biomedical Solutions induced by Biomaterials and Drug Delivery Systems

HUMAN Healthcare


ANIMAL Healthcare


History

2017

May.  Approval of product license on styptic powder, AniClot™-P, by KQIA


May.  Approval of manufacturing license on medical device for animal by KQIAc


Apr.  Certification of ISO 9001:2008/ KS Q ISO 9001:2009


Mar.  KFDA approval of manufacturing license on medical device

2016

Dec.  Research project funded by KSMBAb 


Sep.  Establishment of company-annexed institute


Jun.  Accreditation of Venture Company by KIBOa 


Jun.  Establishment of Theracion Biomedical Co. Ltd

aKIBO: Korea technology finance corporation

bKSMBA: Korean small and medium business Administration 

cKQIA: Korean Animal and Plant Quarantine Agency

 Our Technology

Business


Research & Development


Technology


What is Styptic Hemostat?

■ A handy tool and pet first aid kit for pet owners available online or via local pet supply store, in grooming and care section


■ Basic functions

- It stop bleeding by promoting clotting

- Some varieties contain topical pain relieving agent and antimicrobial to prevent infection


■ Applications involving bleeding due to

- Nail clipping, tail docking,

- wing clipping, beak trimming,

- minor superficial cuts and incisions

<Bleeding in nail trimming>

Mechanism of Styptic Hemostat

■ Hemostasis by contracting blood vessels, vasoconstriction


■ Occlusion of vessels via protein coagulation and precipitation through the dual action of its acidity and the oxidizing capacity of its subsulfate group

Theracion Biomedical

Theracion Biomedical’s mission is to restore patients’ health and
quality of life by delivering innovative technologies.